Found 4887 chains in Genus chains table. Displaying 251 - 300. Applied filters: Proteins

Search results query: 4-Layer Sandwich

Total Genus Sequence Length pdb Title
61 222 5l5yL Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with carfilzomib
68 250 5l5wA Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133)
57 204 5l5wI Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133)
62 220 5lezH Human 20s proteasome complex with oprozomib in mg-acetate at 2.2 angstrom
63 241 5l66G Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with bortezomib
58 226 5l69H Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16
71 243 5l5vF 'yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18
57 204 5l5uI Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17
64 237 5lexC Native human 20s proteasome in mg-acetate at 2.2 angstrom
65 230 5lf7A Human 20s proteasome complex with ixazomib at 2.0 angstrom
61 231 5l5xE Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with onx 0914
152 399 5lmcA Oxidized flavodiiron core of escherichia coli flavorubredoxin, including the fe-4sg atoms from its rubredoxin domain
61 231 5l64E Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18
63 241 5l5zG Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with bortezomib
62 231 5l60E Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with pr-924
67 200 5leyK Human 20s proteasome complex with oprozomib at 1.9 angstrom
54 196 5lf3J Human 20s proteasome complex with bortezomib at 2.1 angstrom
70 243 5l62F Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16
62 220 5le5H Native human 20s proteasome at 1.8 angstrom
68 213 5lf4L Human 20s proteasome complex with delanzomib at 2.0 angstrom
69 244 5l64B Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18
59 196 5l5wN Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133)
69 243 5l60F Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with pr-924
70 243 5l67F Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with pr-924
68 242 5l6aD Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17
58 204 5l61I Yeast 20s proteasome with human beta5c (1-138) and human beta6 (99-132) in complex with epoxyketone inhibitor 14
57 202 5lexN Native human 20s proteasome in mg-acetate at 2.2 angstrom
69 243 5l66F Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with bortezomib
67 230 5lf4A Human 20s proteasome complex with delanzomib at 2.0 angstrom
69 233 5lttM Yeast 20s proteasome with human beta5i (1-138; r57t)in complex with pr-924
68 242 5l5wD Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133)
61 230 5lexA Native human 20s proteasome in mg-acetate at 2.2 angstrom
61 231 5l63E Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17
59 196 5l5iN Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 9
74 248 5lf1B Human 20s proteasome complex with dihydroeponemycin at 2.0 angstrom
58 204 5l69I Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16
63 222 5l6aL Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17
58 226 5l5pH Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17
58 222 5l65L Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with carfilzomib
65 250 5l60A Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with pr-924
68 233 5l62M Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16
66 237 5lf4C Human 20s proteasome complex with delanzomib at 2.0 angstrom
66 240 5l5oC Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16
71 244 5lttB Yeast 20s proteasome with human beta5i (1-138; r57t)in complex with pr-924
63 241 5l6bG Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with onx 0914
59 196 5l5uN Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17
57 226 5l5tH Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16
68 240 5l63C Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17
65 250 5l61A Yeast 20s proteasome with human beta5c (1-138) and human beta6 (99-132) in complex with epoxyketone inhibitor 14
57 202 5lf4N Human 20s proteasome complex with delanzomib at 2.0 angstrom